Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Cellular and Molecular Life Sciences Année : 2021

Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells

Résumé

Overexpression of EGFR drives glioblastoma (GBM) cell invasion but these tumors remain resistant to EGFRtargeted therapies such as tyrosine kinase inhibitors (TKIs). Endocytosis, an important modulator of EGFR function, is often dysregulated in glioma cells and is associated with therappy resistance. However, the impact of TKIs on EGFR endocytosis has never been examined in GBM cells. In the present study, we showed that gefitinib and other tyrosine kinase inhibitors induced EGFR accumulation in early-endosomes as a result of an increased endocytosis. Moreover, TKIs trigger early-endosome re-localization of another membrane receptor, the fibronectin receptor alpha5beta1 integrin, a promising therapeutic target in GBM that regulates physiological EGFR endocytosis and recycling in cancer cells. Super-resolution dSTORM imaging showed a close-proximity between beta1 integrin and EGFR in intracellular membrane compartments of gefitinib-treated cells, suggesting their potential interaction. Interestingly, integrin depletion delayed gefitinib-mediated EGFR endocytosis. Co-endocytosis of EGFR and alpha5beta1 integrin may alter glioma cell response to gefitinib. Using an in vitro model of glioma cell dissemination from spheroid, we showed that alpha5 integrin-depleted cells were more sensitive to TKIs than alpha5-expressing cells. This work provides evidence for the first time that EGFR TKIs can trigger massive EGFR and alpha5beta1 integrin co-endocytosis, which may modulate glioma cell invasiveness under therapeutic treatment.
Fichier principal
Vignette du fichier
Manuscrit Blandin et al., 2021-CMLS.pdf (1.69 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03380486 , version 1 (28-11-2022)

Identifiants

Citer

Anne-Florence Blandin, Elisabete Cruz da Silva, Marie-Cécile Mercier, Oleksandr Glushonkov, Pascal Didier, et al.. Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells. Cellular and Molecular Life Sciences, 2021, 78 (6), pp.2949-2962. ⟨10.1007/s00018-020-03686-6⟩. ⟨hal-03380486⟩
39 Consultations
79 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More